Compounds > 2-piperidone

Page last updated: 2024-08-21

2-piperidone and Malignant Melanoma

2-piperidone has been researched along with Malignant Melanoma in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	4 (66.67)	2.80

Authors

Authors	Studies
Flaherty, KT; Henary, HA; Johnson, DB; Lewis, KD; Long, GV; Moschos, SJ; Puzanov, I; Sandhu, S; Sullivan, RJ; Upreti, VV; Wong, H	1
Border, EC; Pumphrey, NJ; Simister, PC; Vieira, JF	1
Costa-Lotufo, LV; Dartora, VFMC; de Matos, JKR; de Oliveira, EA; Giacone, DV; Lopes, LB; Maria-Engler, SS; Miranda, DAG; Passos, JS; Silveira, ER	1
He, Y; Li, W; Qian, Y; Yang, Y; Zhang, J; Zhou, D	1
Fofaria, NM; Srivastava, SK	1
Bai, H; Chen, F; Huang, C; Liu, G; Peng, C; Song, E; Song, Y; Wang, H; Wu, C; Zeng, P; Zhang, B; Zhang, P	1

Trials

1 trial(s) available for 2-piperidone and Malignant Melanoma

Article	Year
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study. Investigational new drugs, 2022, Volume: 40, Issue:5 Topics: Acetates; Antineoplastic Combined Chemotherapy Protocols; Humans; Melanoma; Nausea; Piperidones; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Tumor Suppressor Protein p53	2022

Other Studies

5 other study(ies) available for 2-piperidone and Malignant Melanoma

Article	Year
Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy. Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:7 Topics: Benzeneacetamides; Humans; Immunotherapy; Melanoma; Peptides; Piperidones; Receptors, Antigen, T-Cell; Receptors, Antigen, T-Cell, alpha-beta	2022
Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models. International journal of biological macromolecules, 2020, Dec-15, Volume: 165, Issue:Pt A Topics: Alginates; Cell Proliferation; Chitosan; Cytotoxins; Emulsions; Humans; Melanocytes; Melanoma; Nanoparticles; Piperidones; Skin Neoplasms	2020
The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells. Current cancer drug targets, 2021, Volume: 21, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Cell Line, Tumor; Curcumin; Humans; Melanoma; Piperidones	2021
Critical role of STAT3 in melanoma metastasis through anoikis resistance. Oncotarget, 2014, Aug-30, Volume: 5, Issue:16 Topics: Animals; Anoikis; Cell Line, Tumor; Gene Knockdown Techniques; Heterografts; Humans; Male; Melanoma; Mice; Mice, SCID; Phosphorylation; Piperidones; Signal Transduction; STAT3 Transcription Factor; Transfection; Tyrphostins	2014
MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. Toxicology letters, 2015, May-05, Volume: 234, Issue:3 Topics: Antineoplastic Agents; Benzylidene Compounds; Blotting, Western; Cell Line, Tumor; Cell Movement; Curcumin; Epithelial-Mesenchymal Transition; Fluorescent Antibody Technique; HMGA2 Protein; Humans; Melanoma; MicroRNAs; Piperidones; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation	2015